909106-60-1 (A 876828)
1
Identification
Name |
A 876828
|
Formula |
C30H32N4O6S2
|
MW |
608.73 |
CAS No. |
909106-60-1 |
EINECS |
|
Smiles |
CS(=O)(NC1=CC=C(C2=C1)N=C(C3=C(O)C4=C(C=CC=C4)[[email protected]@](NCC5=CC=CC=C5)(CCC(C)C)C3=O)NS2(=O)=O)=O |
Synonyms |
Methanesulfonamide, N-[3-[(4S)-3,4-dihydro-1-hydroxy-4-(3-methylbutyl)-3-oxo-4-[(phenylmethyl)amino]-2-naphthalenyl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl]-; (S)-N-(3-(4-(benzylamino)-1-hydroxy-4-isopentyl-3-oxo-3,4-dihydronaphthalen-2-yl)-1,1-dioxido-2H-benzo[e][1,2,4]thiadiazin-7-yl)methanesulfonamide |
InChI |
InChI=1S/C30H32N4O6S2/c1-19(2)15-16-30(31-18-20-9-5-4-6-10-20)23-12-8-7-11-22(23)27(35)26(28(30)36)29-32-24-14-13-21(33-41(3,37)38)17-25(24)42(39,40)34-29/h4-14,17,19,31,33,35H,15-16,18H2,1-3H3,(H,32,34)/t30-/m0/s1 |
3
Protocol(Only for Reference)
Cell Experiment
Animal Experiment
4
Physical and Chemical Properties
Appearance: |
EBNumber:EB000023645 |
Storage condition
Solubility
5
Mechanism and Indication
6
Clinical Information
Product Name |
Sponsor & Collaborators |
Indications |
Start Date |
End Date |
Phase |
A 876828
|
- |
|
|
|
No Development Reported |
7
Safety Data of A 876828
10
Related Products
Other Forms of 909106-60-1
Recommended Compounds in
Recommended Compounds in Same Indication